The current study used data from the population-based Measuring Your Health (MY-Health) study. The MY-Health study design and methods have been described in detail elsewhere [31]. Briefly, 15,300 individuals diagnosed with cancer between 2010 and 2012 were contacted by four Surveillance, Epidemiology, and End Results (SEER) cancer registries (California [2], Louisiana, and New Jersey). A total of 5506 individuals completed a self-report, mail-based survey for a response rate of 36%. We used the following inclusion criteria: (1) completed the baseline MY-Health survey between 6 and 12 months from diagnosis (N = 162 excluded), (2) were diagnosed with their first cancer (prostate, colorectal, non-small cell lung, Non-Hodgkin lymphoma, female breast, uterine, or cervical) at the age of 65 years or older (N = 3240 excluded), and (3) had Stage I–IV cancer based on the derived AJCC 7th edition staging criteria (N = 85 excluded). The final sample was N = 2019. The research design and study methods for the MY-Health study were approved by the Institutional Review Board at Georgetown University.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.